IL1A and posterior cortical atrophy: Indeed, the individual genes modulated by chronic IL-1 exposure that reportedly function in PCa disease can be explored as novel therapeutic targets, but it will also be important to interrogate the signaling networks that integrate the global changes in chronic IL-1-induced gene expression, including those that are unique to the different cell backgrounds.